Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024
Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) ("AHI" or the "Company") would like to inform shareholders that the Company will be expanding the current biometric assessment suite with on-mobile device Atrial Fibrillation (AF) service in quarter 2 of 2024 after signing a binding agreement with Qompium NV
Advanced Health Intelligence Ltd (ASX: AHI)（纳斯达克股票代码：AHI）（“AHI” 或 “公司”）谨通知股东，在与Qompium NV签署具有约束力的协议后，公司将在2024年第二季度通过移动设备心房颤动（AF）服务扩展当前的生物识别评估套件
AHI will expand Biometric Health Assessment (BHA) with a mobile service for detecting atrial fibrillation and heart rhythm abnormality. • Up to 40% of atrial fibrillation (AF) patients are asymptomatici . • AHI will launch a Mobile Phone-Based AF-Scan for Atrial Fibrillation Assessment. • The application has medical approval in Australia, USA, Singapore, EU, UK, UAE and Saudi Arabia for near clinical. • The global prevalence of atrial fibrillation (AF) is approximately 60 million cases. ii • AF increases the risk of stroke five-fold.iii • AF is a prevalent arrhythmia affecting as many as 1 in 4 people over 40.iv
AHI 将扩大生物识别健康评估 (BHA) 的范围，推出用于检测心房颤动和心律异常的移动服务。• 高达 40% 的心房颤动 (AF) 患者无症状。• AHI 将推出基于手机的 AF-Scan 进行心房颤动评估。• 该应用程序已在澳大利亚、美国、新加坡、欧盟、英国、阿联酋和沙特阿拉伯获得医学批准接近临床。• 心房颤动 (AF) 的全球患病率约为 6,000 万例。ii • 房颤使中风风险增加五倍。iii • 房颤很普遍心律失常影响超过 40.iv 的人，每四人中就有一人受到心律失常的影响